Sunday, October 24, 2021

Bajaj Healthcare launches ‘Ivejaj’ tablets for Covid treatment – ET HealthWorld

Drug firm Bajaj Healthcare on Tuesday announced the launch of its anti-parasitic drug ‘Ivejaj’, which can be used for treatment of Covid infections.

The company has received approval from India’s drug regulator DCGI to manufacture and market the tablets, it said in a BSE filing.

Bajaj Healthcare said it has successfully developed the active pharmaceutical ingredient and the formulation for Ivermectin through its own in-house R&D team.

The DCGI has granted permissions to supply ‘Ivejaj’ in the domestic as well as overseas markets, Bajaj Healthcare said.

Shares of the company rose 2.71 per cent to Rs 603.30 apiece on BSE.

Follow and connect with us on , Facebook, Linkedin

Source link

Latest Articles

Widely used chemical linked to 1,00,000 US deaths per year: Study

NEW YORK: Daily exposure to phthalates, a group of chemicals used in everything from plastic containers to makeup, may lead to approximately 100,000 deaths...

Foods to Reduce Inflammation and Strengthen the Immune System

Did you know that you can greatly reduce inflammation and boost your immune system by simply incorporating more anti-inflammatory foods and beverages into your...

Personal Selling

INTRODUCTION Early sellers and traders were not held in high esteem. The Roman word for salesman meant ‘Cheater’ and...

Building Muscle on a Vegan Diet

There are a lot of  misconceptions surrounding veganism. The notion that those who practice it are lacking in protein and therefore muscles is the...

Electrodes in brain new hope for severe cases of epilepsy

Neurosurgeons at All India Institute of Medical Sciences have devised a new technique for operating on children suffering from a severe form of epilepsy...